mediastinal gray zone lymphoma
mediastinal gray zone lymphoma
Explore linked clinical trials. Standard reference: MONDO:00040201 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mediastinal gray zone lymphoma, neoplasm | Active, not recruiting | Phase 2 | 2026-02-06 | NCT03749018 |